Zsófia Király
YOU?
Author Swipe
View article: The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus—A Pilot Study
The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus—A Pilot Study Open
Cutaneous lupus erythematosus (CLE) is an autoimmune skin disease with various clinical forms, including the subtypes of discoid lupus erythematosus (DLE) and subacute cutaneous lupus erythematosus (SCLE). The altered function of the progr…
View article: Myositis specific autoantibodies – What is the clinical usefullness?
Myositis specific autoantibodies – What is the clinical usefullness? Open
The authors describe the myositis-specific and myositis-associated antibodies (MSA-s) in idiopathic inflammatory myopathies and dermatomyositis, with particular emphasis on aspects of clinical relevancy. The frequency and clinical signific…
View article: Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus Open
The pathomechanism of various autoimmune diseases is known to be associated with the altered function of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) axis. We aimed to investigate the role of this pathway and inflamm…
View article: Cutaneous lupus erythematosus, skin or systemic autoimmune disease?
Cutaneous lupus erythematosus, skin or systemic autoimmune disease? Open
The authors present the different clinical forms of cutaneous lupus erythematosus and their prognostic relevance, along with discusson of the uncommon subtypes of the disease. Furthermore, in addition to the lupus specific cutaneous sympto…